Mostrando 5 resultados de: 5
Filtros aplicados
Publisher
Cancers(1)
Nanomedicine(1)
Nanomedicine-Based Approaches for the Treatment of Dementia(1)
Pharmaceutics(1)
Small(1)
Área temáticas
Farmacología y terapéutica(5)
Enfermedades(4)
Medicina y salud(2)
Cirugía y especialidades médicas afines(1)
Fisiología y materias afines(1)
Origen
scopus(5)
Epigallocatechin-3-gallate PEGylated poly(lactic-co-glycolic) acid nanoparticles mitigate striatal pathology and motor deficits in 3-nitropropionic acid intoxicated mice
ArticleAbstract: Aim: To compare free and nanoparticle (NP)-encapsulated epigallocatechin-3-gallate (EGCG) for the trPalabras claves:3-nitropropionic acid, Epigallocatechin-3-gallate, Huntington's disease, neurodegenerative diseases, PLGA-PEG, Polymeric nanoparticlesAutores:Antoni Camins, Auladell C., Barenys M., Cano A., Espina M., Ettcheto M., Folch J., García M.L., Kühne B.A., Sanchez-Lopez E., Souto E.M.B., Turowski P.Fuentes:scopusMemantine-Loaded PEGylated Biodegradable Nanoparticles for the Treatment of Glaucoma
ArticleAbstract: Glaucoma is a multifactorial neurodegenerative disease associated with retinal ganglion cells (RGC)Palabras claves:drug delivery, glaucoma, Memantine, Nanoparticles, PLGA-PEGAutores:Antoni Camins, Calpena A.C., Cordeiro M.F., Davis B.M., Egea M.A., Espina M., Ettcheto M., García M.L., Guo L., Ravindran N., Sanchez-Lopez E., Silva A.M., Souto E.M.B.Fuentes:scopusLipid Nanoparticles for the Posterior Eye Segment
ReviewAbstract: This review highlights the application of lipid nanoparticles (Solid Lipid Nanoparticles, NanostructPalabras claves:Drug transport, lipid nanoparticles, NLC, Ocular barriers, Ocular drug delivery, Posterior segment, SLNAutores:Antoni Camins, Bonilla L., Cano A., Espina M., Ettcheto M., García M.L., Sanchez-Lopez E., Severino P., Souto E.M.B.Fuentes:scopusLipid nanocarriers for hyperproliferative skin diseases
ReviewAbstract: Hyperproliferative skin diseases (HSD) are a group of diseases that include cancers, pre-cancerous lPalabras claves:Antiproliferative drugs, Hyperproliferative skin diseases, lipid nanoparticles, Liposomes, Skin cancerAutores:Cano A., Chorilli M., de Souza A.L.R., Gremião M.P.D., Karczewski J., Kolenyak Fernanda Dos Santos, Sanchez-Lopez E., Souto E.M.B., Staszewski R., Zielińska A.Fuentes:scopusPolymeric nanoparticles as drug delivery systems for dementia
Book PartAbstract: Dementia affects around 50 million people worldwide and it is one of the main causes of disability aPalabras claves:Alzheimer’s disease, dementia, drug delivery, Nanomedicine, PLGA, Polymeric nanoparticlesAutores:Antoni Camins, Cano A., Espina M., Esteruelas G., Ettcheto M., García M.L., Sanchez-Lopez E., Souto E.M.B.Fuentes:scopus